Fast Five Quiz: Late-Onset Pompe Disease
Multiple genetic variants have been associated with LOPD. However, the c.-32-13T>G splice site variant is found in up to 90% of adults and 50% of pediatric patients. Patients with LOPD often have compound heterozygous genotypes, with one allele carrying the common c.-32-13T>G splice-site variant and the other harboring a more deleterious GAA mutation (eg, nonsense, frameshift, or large deletion).
Other variants— such as p.Arg854*, p.Asp645Glu, and c.1935C>A — are more commonly seen in infantile forms of Pompe disease.
Learn more about the pathophysiology of LOPD.
Diagnosis of LOPD typically follows a two-step approach: first, measuring GAA enzyme activity (often via dried blood spot assay) followed by confirmatory molecular genetic testing to identify pathogenic GAA variants.
Although once considered a first-line diagnostic tool for LOPD, muscle biopsy is no longer preferred due to its invasive nature and the non-specificity of histologic findings. Muscle biopsy may still be considered in rare, ambiguous cases when enzyme and genetic testing are inconclusive or conflicting.
CK levels might be elevated in some patients but are nonspecific and primarily serve to raise clinical suspicion.
Learn more about the workup for LOPD.
Enzyme replacement therapy (ERT) has significantly changed the natural history of the disease by improving survival and stabilizing motor and respiratory function. However, key limitations in skeletal muscle uptake and variability in clinical response remain. This is due to low expression of the mannose-6-phosphate receptor in muscle tissue, which hampers enzyme internalization. As a result, patients might experience a limited or plateaued response. Newer approaches, including modified ERT and gene therapy, are being developed to address this issue.
High toxicity to cardiac muscle, uniform patient response, and development of cardiac hypertrophy have not been reported as key limitations.
Learn more about treatment options for LOPD.
NBS programs have reshaped the understanding of Pompe disease, particularly LOPD. A significant proportion of screen-positive newborns harbor genetic variants associated with LOPD, including pseudo deficiency alleles and variants of uncertain significance. These individuals are often asymptomatic at birth and might not develop symptoms for years, if at all. This has raised important clinical questions around monitoring, counseling, and when (or whether) to initiate therapy; expanded screening has also revealed that the true prevalence of LOPD might be higher than historical estimates suggested.
Learn more about the management of LOPD.
Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication. Lead image: UCSF/Science Source
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
31 minutes ago
- Medscape
AI Meets Frailty: Rethinking Hematology in Older Patients
MILAN — Conditions like leukemia and myelodysplastic syndromes become more prevalent with age, but older patients often present with multiple comorbidities, greater physical and cognitive frailty, and diminished tolerance to intensive therapies. This creates complex challenges for the hematologist. Matteo Giovanni Della Porta, MD 'It is not enough to focus solely on the disease; the patient must be assessed as a whole, balancing treatment efficacy with quality of life,' Matteo Giovanni Della Porta, MD, head of the Leukemia Unit at Humanitas Cancer Center and professor of hematology at Humanitas University, Milan, Italy, told Medscape Medical News . 'This poses a significant clinical challenge that demands multidisciplinary expertise and increasingly personalized therapeutic strategies.' Can artificial intelligence (AI) play a role in addressing this challenge? Experts discussed the pros and cons here on the opening day of the 2025 European Hematology Association (EHA 2025) Congress. AI: Friend or Foe? Polypharmacy is common in older patients, and it is simply not feasible for a single physician to know and recall all possible interactions between medications and the therapies required to treat a hematologic condition. 'Every clinical decision must be tailored to the patient's age, comorbidities, and pharmacologic complexity, where efficacy meets vulnerability,' said Torsten Haferlach, MD, co-founder of the MLL Munich Leukemia Laboratory in Germany, speaking at the session titled 'Aging and Hematology: Artificial Intelligence in Geriatric Hematology.' AI can help address these limitations, provided that human oversight is maintained, he said. Torsten Haferlach, MD 'AI can integrate heterogeneous clinical, functional, and social data to develop personalized risk profiles, predict treatment tolerability, and recommend more appropriate care pathways. In the future, AI-driven predictive models may support complex clinical decision-making, helping ensure that treatments for older patients are better balanced, more effective, and more sustainable,' Della Porta explained to Medscape Medical News . Large language models are now being used to support automatic diagnosis, often generating clinically usable results. But Della Porta cautioned that most AI tools are not yet optimized for older populations. A recent scoping review of FDA-approved AI-based devices found that only 0.4% focused exclusively on geriatric health. Reshaping the Doctor-Patient Relationship Still, as AI increasingly takes over administrative tasks, such as note taking and report generation, it might give clinicians more time for meaningful patient interaction. 'AI does not replace physicians, but it can make their work more effective and help foster a closer connection with the patient, also through building trust,' said Esther Lueje, MD, a geriatrician at Fundación Jiménez Díaz University Hospital, Madrid, Spain. She explained that AI can free up time, reduce diagnostic uncertainty, and support more transparent decision-making. However, Della Porta cautioned while speaking with Medscape Medical News , that '[i]f patients feel that technology is replacing empathy or meaningful dialogue, there is a risk of emotional detachment. The key point is that AI should serve the doctor–patient relationship, not hinder it.' Lueje also warned that integrating large language models into daily practice comes with challenges: hallucinations, clinical errors, the need for medical oversight, and limited digital literacy among physicians. 'We have a stethoscope in one hand but no prompt — or the skill to write one — in the other,' Haferlach also noted. Synthetic Patients, Virtual Trials Another realm for AI integration is synthetic data, which could become as revolutionary as telecommunications and biotechnology. 'Data are the new oil,' said Alfonso Piciocchi, PhD, chief scientific officer and head of the Biostatistics Unit at Fondazione GIMEMA, Italy. Alfonso Piciocchi, PhD In his talk, Piciocchi explored the concept of synthetic patients: AI-generated models that mirror real patient populations, preserving key data correlations. These are not mere simulations, as they preserve the same multivariate structure, correlations, and observed distributions as real-world data. They are primarily used to train AI algorithms while safeguarding patient privacy. 'The generation of synthetic patients is not without risks: if the initial database is not well-defined, the risk of failure can be significant," Piciocchi told Medscape Medical News . However, current experiences indicate that these synthetic patient cohorts closely resemble actual human cohorts and can be effectively used to create control groups in so-called 'virtual' clinical trials or to enhance the representation of under-recruited populations, such as elderly patients, who are often difficult to enroll. In addition to synthetic patients, there is increasing discussion around digital twins: virtual representations of real patients created by integrating biological, clinical, and environmental data. "They allow clinicians to simulate disease progression or predict therapeutic responses before initiating treatment, thereby enhancing personalization of care," Della Porta said, emphasizing that both technologies are already in use in experimental settings and are expected to become integral components of precision medicine in hematology in the coming years.
Washington Post
36 minutes ago
- Washington Post
Dads, healthy fish and the benefits of singing: The week in Well+Being
You are reading our weekly Well+Being newsletter. Sign up here to get it delivered to your inbox every Thursday. This weekend is Father's Day. It's a time that can be joyous or bittersweet, depending on your relationship with your father. The latter is particularly true if your parent has died, like Jordan Sondler's. This week, she writes about how she found deep comfort looking for 'signs' from her father, a tip she learned from a grief-support group. I could definitely relate, since my dad died a few years ago. I have him to thank for my formidable lawn-mowing skills, ability to ride a bike and much more, so I always appreciate the other dads out there, like the one in our Ask a Therapist column looking for the best way to raise his young son with love and affection. But before that … You might know that eating seafood is good for your brain, eyes and heart health. So why aren't you eating more of it? If you don't have it on your regular rotation at mealtimes, you're not alone — 90 percent of adults aren't hitting recommended intake targets. Part of the problem is that the seafood landscape can be confusing. There are so many options — from shrimp to salmon to canned tuna — how do you know which ones to eat? This week, nutrition reporter Anahad O'Connor took a deep dive into the best types of seafood, detailing those that are relatively low in mercury, high in omega-3 fats, sustainable, as well as accessible and affordable. First up is salmon, of course. While farmed salmon can certainly be a good choice, wild salmon is almost always the better option. 'Wild salmon is a triple win because it's high in good fats, low in mercury and sustainable,' Sonya Lunder, the director of community science at the Natural Resources Defense Council, told Anahad. For more great choices, check out our guide to choosing the healthiest seafood. If you are a car karaoke aficionado, you'll be glad to hear that music has the power to soothe the mind, promote brain health and bring people closer together. Singing, listening to music or making music all promote health. And the wonderful part about it is that the barrier to entry is low. Even if you won't be trying out for the opera any time soon, you can reap the benefits, according to our brain health writer, Richard Sima. For example, singing karaoke was linked to increased feelings of flow and meaning in life, reported one 2022 study of 305 older adults, so there's no need to sleep on this wellness trend. 'Nobody says you shouldn't jog if you are not good at it,' Daniel Levitin, a professor emeritus of neuroscience at McGill University and dean of arts and humanities at Minerva University, told Richard. 'That's not the point.' For some great tips on how to use your love of music to create and connect with others, check out our story on the health benefits of making music. This week, our Ask a Therapist columnist is Joshua Coleman, a clinical psychologist in the San Francisco Bay Area and senior fellow with the Council on Contemporary Families. My wife and I have a 4-year-old son. I'm very affectionate with him — I hug him a lot, tell him I love him and comfort him when he cries. But my wife is starting to express concern that I'll make him 'soft.' We're both good parents, but this is starting to create real tension. How do we resolve a parenting difference that touches on something so personal? It is common for people to parent similarly to how they were raised. It's partly role modeling, and partly a way to feel close to our parents by being aligned with them and sharing their values. At the same time, it's common to reinterpret painful childhood experiences in a more favorable light — to convince ourselves that what was hard was ultimately necessary. If your wife had a strict, emotionally distant father, she may have come to believe that his approach helped shape her strength — and that your son will need the same. You don't have to agree about everything in parenting to find common ground. Make it clear that your disagreements are about approach, not character. Get more useful tips on navigating a conflict if you can't agree on a parenting approach by reading the full response below. If you have a question for a therapist about mental health, relationships, sleep, dating or any other topic, email it to AskATherapist@ and we may feature it in a future column. Here are a few things that brought us joy this week. Let's keep the conversation going. We want to hear from you! Email us at wellbeing@ Want to know more about 'joy' snacks? Reporter and former neuroscientist Richard Sima explains what they are and how they can make you feel happier. You can also read his advice as a comic.
Fox News
an hour ago
- Fox News
Cuomo admits to seeing COVID nursing home death report, says he may have altered it
Ahead of the second New York City mayoral debate, former New York Democrat Gov. Andrew Cuomo admitted that, despite previous testimony to Congress to the contrary, he did see the report detailing the number of COVID nursing home deaths and that he may have altered the report. Speaking with local outlet PIX 11 News on Wednesday, Cuomo said, "I did not recall seeing the report at the time. I did see the report, it turns out." He also said, "I'm sure that if I read the report. I made language changes." Despite this, Cuomo said the published report "was accurate" and that "this has been politicized from day 1." Cuomo, who resigned his governorship in 2021 amid sexual harassment allegations, is the leading candidate running for New York City mayor. However, he continues to face criticism over the misconduct allegations as well as claims that he altered a report to undercount the number of COVID-19 nursing home deaths. During the first New York mayoral debate last week, fellow Democrat opponents blasted Cuomo for allegedly lying to Congress, an allegation pushed by Republicans that the Trump administration is currently investigating. The Trump Department of Justice opened a criminal investigation in May to get to the bottom of whether Cuomo lied to Congress about the decisions he made during the COVID-19 pandemic while serving as governor. Cuomo repeatedly dismissed questions throughout the debate about whether he lied to Congress about his role in drafting a New York State Department of Health report that officials determined had undercounted the number of nursing home deaths during the COVID-19 pandemic. Instead, Cuomo blasted the current investigation as a symptom of partisan politics and insisted the report in question "did not undercount the deaths." Though he admitted on Wednesday to incorrectly testifying about not seeing the report and possibly making changes, Cuomo continued to maintain the accuracy of its numbers. "Let's just be clear for the record, because a lot of misinformation has been spread, New York always followed the federal guidance on what to do with nursing homes from the best federal medical minds available," he said. He noted that the federal guidance "changed over time as the federal officials learned more," saying that "the state and other states followed the federal guidance." "When all is said and done, New York state is No. 38 in the rate of nursing home deaths. Think about that, 38 out of 50 states. Only 12 states had a lower rate of death than New York," he said. Cuomo is expected to again face intense questioning from opponents and moderators about the report during the second mayoral debate on Thursday night.
